Product NDC: | 55513-710 |
Proprietary Name: | Prolia |
Non Proprietary Name: | denosumab |
Active Ingredient(s): | 60 mg/mL & nbsp; denosumab |
Administration Route(s): | SUBCUTANEOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55513-710 |
Labeler Name: | Amgen Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA125320 |
Marketing Category: | BLA |
Start Marketing Date: | 20100605 |
Package NDC: | 55513-710-01 |
Package Description: | 1 SYRINGE in 1 CARTON (55513-710-01) > 1 mL in 1 SYRINGE |
NDC Code | 55513-710-01 |
Proprietary Name | Prolia |
Package Description | 1 SYRINGE in 1 CARTON (55513-710-01) > 1 mL in 1 SYRINGE |
Product NDC | 55513-710 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | denosumab |
Dosage Form Name | INJECTION |
Route Name | SUBCUTANEOUS |
Start Marketing Date | 20100605 |
Marketing Category Name | BLA |
Labeler Name | Amgen Inc |
Substance Name | DENOSUMAB |
Strength Number | 60 |
Strength Unit | mg/mL |
Pharmaceutical Classes |